Spectrum of neurological complications following COVID-19 vaccination
RK Garg, VK Paliwal - Neurological Sciences, 2022 - Springer
COVID-19 vaccines have brought us a ray of hope to effectively fight against deadly
pandemic of COVID-19 and hope to save lives. Many vaccines have been granted …
pandemic of COVID-19 and hope to save lives. Many vaccines have been granted …
Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review
D Al‐Ali, A Elshafeey, M Mushannen… - Journal of cellular …, 2022 - Wiley Online Library
Since COVID‐19 took a strong hold around the globe causing considerable morbidity and
mortality, a lot of effort was dedicated to manufacturing effective vaccines against SARS …
mortality, a lot of effort was dedicated to manufacturing effective vaccines against SARS …
[HTML][HTML] Intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 in vitro in human liver cell line
M Aldén, F Olofsson Falla, D Yang… - Current issues in …, 2022 - mdpi.com
Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer and
BioNTech, showed reversible hepatic effects in animals that received the BNT162b2 …
BioNTech, showed reversible hepatic effects in animals that received the BNT162b2 …
Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: a self-controlled case series study
Background This study aims to evaluate the association between thromboembolic events
and hemorrhagic stroke following BNT162b2 and CoronaVac vaccination. Methods Patients …
and hemorrhagic stroke following BNT162b2 and CoronaVac vaccination. Methods Patients …
[HTML][HTML] Stroke associated with COVID-19 vaccines
Objectives Development of safe and effective vaccines against coronavirus disease 2019
(COVID-19) remains the cornerstone of controlling this pandemic. However, there are …
(COVID-19) remains the cornerstone of controlling this pandemic. However, there are …
Cardiovascular complications of COVID-19 vaccines
R Liu, J Pan, C Zhang, X Sun - Frontiers in cardiovascular medicine, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) has become a global public health catastrophe.
Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is …
Vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is …
Coagulopathy and fibrinolytic pathophysiology in COVID-19 and SARS-CoV-2 vaccination
S Yamada, H Asakura - International Journal of Molecular Sciences, 2022 - mdpi.com
Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and is frequently complicated by thrombosis. In some cases of …
coronavirus 2 (SARS-CoV-2) and is frequently complicated by thrombosis. In some cases of …
Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks
Introduction Since its emergence, there have been huge efforts to design vaccines against
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …
Inflammatory myopathy following coronavirus disease 2019 vaccination: a systematic review
Y Ding, Y Ge - Frontiers in Public Health, 2022 - frontiersin.org
Introduction Reports of unexpected side effects have accompanied the vaccination of larger
proportions of the population against coronavirus disease 2019 (COVID-19), including a few …
proportions of the population against coronavirus disease 2019 (COVID-19), including a few …
Association of cerebral venous thrombosis with mRNA COVID-19 vaccines: a disproportionality analysis of the World Health Organization pharmacovigilance …
J Park, MS Park, HJ Kim, TJ Song - Vaccines, 2022 - mdpi.com
Cerebral venous thrombosis (CVT), a rare thrombotic event that can cause serious
neurologic deficits, has been reported after some ChAdOx1 nCoV-19 vaccinations against …
neurologic deficits, has been reported after some ChAdOx1 nCoV-19 vaccinations against …